Market open

Aptorum Group Limited/$APM

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Aptorum Group Limited

Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.

Ticker

$APM
Trading on

Industry

Biotechnology

Employees

3

ISIN

KYG6096M1226

APM Metrics

BasicAdvanced
$6.1M
-
-$0.78
-
-
$6.1M
$1.34
$0.69
100K
0.221
0.221
0.12
28.487
-26.82%
-13.40%
-30.62%
0.23
0.23
-3.945
25.27%
-52.16%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $APM

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs

What’s the current market cap for Aptorum Group Limited stock?

What is the P/E ratio for Aptorum Group Limited stock?

Does Aptorum Group Limited stock pay dividends?

When is the next Aptorum Group Limited dividend payment date?

What is the beta indicator for Aptorum Group Limited?